NMN and beyond: Start-up of the Year beefs up cellular health platform
Longevity Life Sciences, which bagged the Start-up of the Year at this year’s NutraIngredients-Asia Awards, has set its sights on building a cellular health ingredient platform following the success of CellVive NMN – the first NMN ingredient to be approved by the Therapeutic Goods Administration (TGA) for use in dietary supplements.
The Australia-based company has partnered with Mitsubishi Gas Chemical (MGC), one of Japan’s most established manufacturers of pharmaceutical-grade molecular compounds, to bring a pipeline of cellular health compounds to the Australian market through its proprietary CellVive ingredient platform in a multi-year partnership.
The first ingredient that it plans to introduce to Australia from MGC is pyrroloquinoline quinone (PQQ), commercially available as BioPQQ.
Eye health supplement launches broaden focus with targeted formats and claims
Eye health supplements are evolving the familiar lutein-and-zeaxanthin story, with recent launches reflecting a more segmented category shaped by blue light culture.
Specifically, companies are pairing familiar carotenoids with omega-3s, B vitamins, hyaluronic acid, antioxidants, hydration-support ingredients and even habit-building technology.
Japanese firm YURU Co Ltd, for instance, introduced its LUTE VITA eye supplement containing LUZvision liposomal lutein, as well as astaxanthin, coenzyme Q10, low molecular weight hyaluronic acid and collagen peptides etc.
Caffeine dominates esports supplements - review
More than 75% of nutritional supplements evaluated for electronic sports (esports) performance contain caffeine, according to a systematic review of randomised controlled trials.
The systematic review involved 13 RCTs published between 2019 and 2025, conducted across the US, Spain, Australia, Japan, Taiwan and India.
Findings revealed that caffeine was the most popular ingredient in esports supplements, with links to improvements in cognitive function, gaming performance and psychological mood.
Pollen extract combination may improve menopause symptoms and bone health
Purified pollen cytoplasm (PCP), vitamin D and vitamin K2 may help reduce hot flashes and improve physical and mood-related menopause symptoms while supporting bone health, according to a new study published in Nutrients.
The study, funded by Shionogi SRL, the Italian operating subsidiary of Japanese company Shionogi & Co., investigated the effect of Femal Osteo, a Shionogi supplement containing 320mg of PCP, 25mcg of vitamin D3, 10mg of vitamin E, 180mcg of vitamin K2 and 1.4mg of vitamin B6.
Participants in the group that took Femal Osteo were observed to have improvements in symptoms, along with reduced markers of bone turnover after three months of supplementation.
Scallop-derived plasmalogens show promise for cognitive function
Older adults showed improved cognitive scores when taking a supplement containing scallop-derived plasmalogens (sPls) compared with placebo, a study finds.
The study is funded by B&S Corporation Co Ltd, which manufactures and markets scallop plasmalogen. It evaluated memory and brain health in 66 Japanese adults with below-average verbal memory, who took the supplement for 12 weeks.
“Overall, dietary sPls may have the potential to support cognitive function in this population, although further studies are needed to confirm these findings, establish their generalizability, and evaluate long-term safety,” the Japanese researchers wrote in Frontiers in Nutrition.
